BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7849309)

  • 21. Cancer stem cells revisited.
    Batlle E; Clevers H
    Nat Med; 2017 Oct; 23(10):1124-1134. PubMed ID: 28985214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.
    Lopez-Bertoni H; Li Y; Laterra J
    Biol Med (Aligarh); 2015 Nov; 7(Suppl 2):. PubMed ID: 27158195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine models of acute leukemia: important tools in current pediatric leukemia research.
    Jacoby E; Chien CD; Fry TJ
    Front Oncol; 2014; 4():95. PubMed ID: 24847444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
    Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival.
    Duggal R; Geissinger U; Zhang Q; Aguilar J; Chen NG; Binda E; Vescovi AL; Szalay AA
    J Transl Med; 2013 Jun; 11():155. PubMed ID: 23800258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cancer stem cell: premises, promises and challenges.
    Clevers H
    Nat Med; 2011 Mar; 17(3):313-9. PubMed ID: 21386835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infant acute lymphoblastic leukemia: Lessons learned and future directions.
    Pieters R
    Curr Hematol Malig Rep; 2009 Jul; 4(3):167-74. PubMed ID: 20425430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
    Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive assessment of tumor cell proliferation in animal models.
    Edinger M; Sweeney TJ; Tucker AA; Olomu AB; Negrin RS; Contag CH
    Neoplasia; 1999 Oct; 1(4):303-10. PubMed ID: 10935484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of reporter genes for optical measurements of neoplastic disease in vivo.
    Contag CH; Jenkins D; Contag PR; Negrin RS
    Neoplasia; 2000; 2(1-2):41-52. PubMed ID: 10933067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visualizing the kinetics of tumor-cell clearance in living animals.
    Sweeney TJ; Mailänder V; Tucker AA; Olomu AB; Zhang W; Cao Ya; Negrin RS; Contag CH
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12044-9. PubMed ID: 10518573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome.
    Kumagai M; Manabe A; Pui CH; Behm FG; Raimondi SC; Hancock ML; Mahmoud H; Crist WM; Campana D
    J Clin Invest; 1996 Feb; 97(3):755-60. PubMed ID: 8609232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
    Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.
    Yan Y; Salomon O; McGuirk J; Dennig D; Fernandez J; Jagiello C; Nguyen H; Collins N; Steinherz P; O'Reilly RJ
    Blood; 1996 Oct; 88(8):3137-46. PubMed ID: 8874214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
    Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
    Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
    Uckun FM; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
    Blood; 1995 Feb; 85(4):873-8. PubMed ID: 7849309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
    Uckun FM; Sather HN; Waurzyniak BJ; Sensel MG; Chelstrom L; Ek O; Sarquis MB; Nachman J; Bostrom B; Reaman GH; Gaynon PS
    Leuk Lymphoma; 1998 Aug; 30(5-6):503-14. PubMed ID: 9711913
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.